U.S. Pharmaceuticals & Biotech Upcoming Dividends

Johnson & Johnson

Market Cap: US$366.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Phibro Animal Health

Market Cap: US$993.1m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

Pfizer

Market Cap: US$131.8b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Gilead Sciences

Market Cap: US$134.9b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Amgen

Market Cap: US$149.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Zoetis

Market Cap: US$73.6b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Qiagen

Market Cap: US$9.6b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Viatris

Market Cap: US$10.1b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Agilent Technologies

Market Cap: US$31.5b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Eli Lilly

Market Cap: US$645.8b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Perrigo

Market Cap: US$3.7b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.